Box score
Prolifagen, Inc.
Reported $3M sold in a new Form D filed September 23, 2025 (Doylestown, Pennsylvania).
- Biggest raise
- $3M filed Sep 23, 2025
- League
- Bio & Health Biotechnology
- Based in
- Doylestown, Pennsylvania
- Season rank
- #593 of 1,311 in the Bio & Health League; #4610 of 12,397 overall (2025)
- Incorporated
- 2025
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-09-23 | New notice | $3M | indefinite | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2086999.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Waveclear, Inc. | Bio & Health | $3.5M |
| 2 | Bainbridge Health, Inc. | Bio & Health | $3.4M |
| 3 | Aprea Therapeutics, Inc. rookie | Bio & Health | $3.1M |
| 4 | Peca Labs, Inc. | Bio & Health | $2.7M |
| 5 | Lipella Pharmaceuticals Inc. | Bio & Health | $2.6M |
| 6 | Jabez Biosciences, Inc. rookie | Bio & Health | $2.5M |